Skip to content
GenoLensGenoLens

ATCAY

Chr 19p13.3

ATCAY kinesin light chain interacting caytaxin

Aliases:
BNIP-H
MANE:
ENST00000450849.7

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia with onset in adulthood

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Adult onset neurodegenerative disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Cayman type cerebellar ataxia

    0.72
  • Cerebellar ataxia, Cayman type

    0.71
  • hereditary disease

    0.19
  • Hydrocephalus

    0.16
  • genetic developmental and epileptic encephalopathy

    0.10
  • undetermined early-onset epileptic encephalopathy

    0.10
  • familial infantile myoclonic epilepsy

    0.09
  • developmental and/or epileptic encephalopathy with spike-wave activation in sleep

    0.09
  • Rolandic epilepsy

    0.09
  • Landau-Kleffner syndrome

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Caytaxin

Functions in the development of neural tissues, particularly the postnatal maturation of the cerebellar cortex. May play a role in neurotransmission through regulation of glutaminase/GLS, an enzyme responsible for the production in neurons of the glutamate neurotransmitter. Alternatively, may regulate the localization of mitochondria within axons and dendrites

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.